Navigating the Forces Shaping Oncology in 2021 and Beyond
-
Read External ArticleThe Mainstreaming of Targeted Lung Cancer Treatment
Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.
-
Read ArticleHealth Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals
Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.
-
Read ArticleSpecialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies
Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.
-
Read ArticleHitting the Brakes on Fast-Tracked Drugs
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
- Let's Go
-
Read ArticleTop Takeaways from the 2021 ASCO Annual Meeting
Our chief medical officer highlights noteworthy research and results from clinical oncology's premier event.
-
Watch VideoCMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting
New Century Health CMO, Dr. Andrew Hertler, shares his thoughts on the recent FDA meetings to review the merits of approved cancer drugs.
-
Read ArticleA Redesigned Prior Authorization is Needed in Oncology. Here's How.
Payer strains now top the list of stressors facing oncologists, with prior authorization as the most-cited source of that payer stress.
-
Read ArticleExperts and Execs Weigh In: Oncology Care in 2021 and Beyond
New Century Health recently convened health plan executives, industry experts and oncologists from across the nation to discuss the confluence of forces shaping oncology care in 2021 and beyond.
-
Watch Video
Video: Cancer Care Costs Everyone Too Much. What Can Health Plans Do About It?
New Century Health’s John Davis hosts a virtual “fireside chat” with Dr. Elizabeth Malko, Dr. Vinay Prasad, and Dr. Andrew Hertler.
-
Read ArticlePathways, Portals and Persuasion: Reining in an Overused Cancer Agent
NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.
- Learn More
-
Read External ArticleOncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping
-
Read ArticleHow Real-World Evidence Can Transform High-Value Oncology Pathways
Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.
-
Read ArticleHigh-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend
Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.
-
Read ArticleWill COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?
The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.
-
Read ArticleControlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus
Our CMO Dr. Andrew Hertler outlines value-based payment strategies and tools to help oncologists improve care across the patient journey.
-
Read ArticleCancer Care Costs Everyone Too Much. Here's How We Fix It.
Dr. Andrew Hertler, Chief Medical Officer at New Century Health, demonstrates how clinical pathways improve patient outcomes while decreasing waste and cost.
-
Loading More...
